Health Products

Vyvanse (2015-12-23)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
AD8671BVyvanse
Recalling Firm
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
CapsuleDIN 02322951Lisdexamfetamine Dimesylate 30mg

Introduction

Affected Products

Vyvanse

Reason

Some labels were found missing on product bottles from these lots.

Depth of distribution

Wholesalers across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime